SkyOak Wealth, LLC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 114 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
SkyOak Wealth, LLC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q2 2024$14,960
-32.6%
15,0000.0%0.00%
-40.0%
Q1 2024$22,200
+35.8%
15,0000.0%0.01%
+25.0%
Q4 2023$16,350
-7.6%
15,0000.0%0.00%
-20.0%
Q3 2023$17,700
-16.3%
15,0000.0%0.01%
-16.7%
Q2 2023$21,150
-6.0%
15,0000.0%0.01%
-14.3%
Q1 2023$22,500
+28.2%
15,0000.0%0.01%
+16.7%
Q4 2022$17,550
+3.2%
15,0000.0%0.01%0.0%
Q3 2022$17,000
-29.2%
15,0000.0%0.01%
-25.0%
Q2 2022$24,000
+4.3%
15,0000.0%0.01%
+33.3%
Q1 2022$23,000
-37.8%
15,0000.0%0.01%
-33.3%
Q4 2021$37,000
-2.6%
15,0000.0%0.01%
-10.0%
Q3 2021$38,000
-11.6%
15,0000.0%0.01%
-16.7%
Q2 2021$43,000
+7.5%
15,0000.0%0.01%
+9.1%
Q1 2021$40,000
+53.8%
15,0000.0%0.01%
+37.5%
Q4 2020$26,000
+85.7%
15,0000.0%0.01%
+60.0%
Q3 2020$14,000
+7.7%
15,0000.0%0.01%0.0%
Q2 2020$13,000
+8.3%
15,0000.0%0.01%
-16.7%
Q1 2020$12,000
-7.7%
15,0000.0%0.01%
+50.0%
Q4 2019$13,00015,0000.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q2 2024
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,005,379$33,325,0004.63%
Defender Capital, LLC. 3,794,045$3,709,0003.29%
Prescott General Partners LLC 1,851,851$1,815,0000.07%
Northeast Financial Consultants Inc 693,856$680,0000.07%
Beirne Wealth Consulting Services, LLC 45,000$44,0000.04%
DAFNA Capital Management LLC 95,000$93,0000.04%
Keudell/Morrison Wealth Management 11,705$11,0000.01%
Regent Investment Management LLC 20,000$20,0000.01%
Clarus Wealth Advisors 10,147$10,0000.01%
Summit X, LLC 18,200$18,0000.01%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders